Source link : https://newshealth.biz/health-news/glp-1-ras-unlikely-to-increase-suicide-risk/
TOPLINE: A meta-analysis of randomized controlled trials involving over 59,000 patients with diabetes or obesity showed no statistically significant difference in the risk for suicide between those treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and placebo. METHODOLOGY: Initial reports of increased suicidality in GLP-1 RA users compared with the general population raised concerns […]
The post GLP-1 RAs Unlikely to Increase Suicide Risk first appeared on News Health.
Author : News Health
Publish date : 2025-03-25 09:25:00
Copyright for syndicated content belongs to the linked Source.